Marking the opening of the new manufacturing site of the Berlin Center for Advanced Therapies — bringing cutting-edge cell and gene therapies into clinical practice.
Welcome Address
Prof. Dr. med.Welcome
Dear colleagues,
Dear Ladies and Gentlemen,
it is with great pleasure that I welcome you to the BeCAT 2026 Opening Symposium. The opening of the new manufacturing site of the Berlin Center for Advanced Therapies — BeCAT marks another important milestone for translational cell and gene therapy at Charité and in Berlin.
BeCAT's mission is to bring the promising Advanced Therapy Medicinal Products (ATMPs), with their tremendous potential, into clinical practice. Researchers from Charité, the Berlin Institute of Health at Charité (BIH), and the Max Delbrück Center (MDC), among others, are joining us to collaboratively develop and manufacture drugs for early-stage clinical trials. Furthermore, under Berlin's leadership, we are integrating these ATMPs into national networks such as the National Centre for Tumour Diseases (NCT).
The Opening Symposium offers us the opportunity to discuss the current state and future of academic ATMP development with national and international experts. This is not only about scientific excellence, but also about networks, strategic partnerships, regulatory frameworks, and the question of how we can bring innovative therapies to patients responsibly and effectively.
I warmly invite you to join us in shaping this special day — through scientific exchange, critical discussion, new ideas, and personal encounters. I very much look forward to welcoming you to Berlin on 30 September 2026.
With warm regards
Prof. Dr. med. Annette Künkele-LangerWednesday, 30 September 2026 · 09:00 a.m. – 05:30 p.m. · Forum 3, Campus Virchow-Klinikum. The scientific programme is followed by an evening reception at the Si-M Building. Details are being finalised and will be updated continuously.
Ulrich Kintscher — Vice Dean for Research
Annette Künkele-Langer — BeCAT
“The Power of Networks”
Moderation: Christian Gallus
Ulrike Köhl — Fraunhofer IZI Leipzig, University Hospital Leipzig & SaxoCell Consortium Christopher Baum — National Strategy for Gene- and Cell-Based Therapies Volker Sandig — ProBioGen Michael Aigner — Universitätsklinikum Erlangen Nadine Großmann — FOP e. V. & FU Berlin
Moderation: Michael Schmitt
Philipp Beckhove — Leibniz Institute for Immunotherapy (LIT) Evelyn Ullrich — Universitätsmedizin Frankfurt Maria-Luisa Schubert — Universitätsklinikum Heidelberg
Followed by panel discussion
A way to accelerate Gene and Cell Therapies
Moderation: Lars Bullinger
Michael Hudecek — Universitätsklinikum Würzburg Antonia Busse — Charité – Universitätsmedizin Berlin Christof Scheid — Universitätsklinikum Köln
Moderation: Annette Künkele-Langer
Alessandro Aiuti — Università Vita-Salute San Raffaele; SR-Tiget, IRCCS Ospedale San Raffaele
Moderation: Uta Höpken
Dirk Busch — Institut f. Med. Mikrobiologie, Immunologie und Hygiene, TUM Chiara Bonini — Università Vita-Salute San Raffaele – IRCCS Ospedale San Raffaele
With BeCAT Speed Talks — Georg Duda · Ludovic Vallier · Leila Amini · Armin Rehm
Moderation: Leila Amini
Sean Russell — Telethon Reno Debets — Erasmus MC Rotterdam David Morrow — EATRIS Nathan Yozwiak — Mass General Brigham Silvia Martin Lluesma — Vall d'Hebron Institute of Oncology (VHIO) Lorna Warwick — Lymphoma Coalition
Closing & Wrap-up · Programme ends approx. 17:30
Location
Registration
Thank you for your interest in the Opening Symposium BeCAT 2026. Please register using the form below and familiarize yourself with the terms and conditions of participation.
We look forward to welcoming you to the Charité campus.
Places are limited. A confirmation email will be sent automatically to your address from becat-symposium@charite.de — please also check your spam folder.
Fields marked * are mandatory. Questions? becat-symposium@charite.de
Organization